| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |